13F-HR filed by Velan Capital Investment Management LP
Velan Capital Investment Management LP filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 47 holding rows worth $97,207,327.
- Accession
- 0000938552-25-000003
- Filer
- CIK 1848809
- Filed
- 2025-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 49 entries on the cover page, a total value of $97,207,327 stated on the cover page (in dollars after the unit check, H1), rows summing to $97,207,327 with VALUE read as dollars as filed, 13F file number 028-21996. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HERON THERAPEUTICS INC | 427746102 | COM | 6,986,744 | $15,370,837 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 3,366,945 | $8,316,354 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 185,520 | $8,186,998 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 1,667,800 | $7,104,828 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 185,000 | $7,005,950 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 455,412 | $6,926,817 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 1,433,828 | $6,165,460 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 95,000 | $6,031,550 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 665,000 | $4,980,850 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 300,000 | $4,425,000 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 904,029 | $2,431,838 | dollars as filed | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 917,668 | $2,413,467 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 150,600 | $2,391,528 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 182,083 | $1,775,309 | dollars as filed | |
| EDESA BIOTECH INC | 27966L306 | COM NEW | 687,500 | $1,677,500 | dollars as filed | |
| Instil Bio Inc | 45783C200 | COM NEW | 69,000 | $1,197,840 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 400,000 | $1,160,000 | dollars as filed | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 323,973 | $1,098,268 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 500,000 | $1,065,000 | dollars as filed | |
| GERON CORP | 374163103 | COM | 655,000 | $1,041,450 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 153,500 | $1,033,055 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 747,410 | $911,840 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 111,972 | $896,896 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 1,030,000 | $670,118 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 107,000 | $654,840 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 83,333 | $545,831 | dollars as filed | |
| KIORA PHARMACEUTICALS INC | 49721T507 | COM | 122,223 | $367,891 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 59,000 | $313,290 | dollars as filed | |
| REGULUS THERAPEUTICS INC | 75915K309 | COM | 80,000 | $140,000 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 13,000 | $105,040 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 75,000 | $82,500 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 50,000 | $68,500 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 55,000 | $67,650 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 28,000 | $60,200 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 45,000 | $59,850 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 90,000 | $55,080 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 14,000 | $54,040 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 35,000 | $53,550 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 75,000 | $47,685 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 17,000 | $46,920 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 40,000 | $46,000 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 12,000 | $38,760 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 35,000 | $38,150 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 97,000 | $30,254 | dollars as filed | |
| KRONOS BIO INC | 50107A104 | COM | 35,000 | $28,875 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 25,000 | $12,008 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 45,000 | $11,660 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000938552-25-000003 | this filing | 2025-05-15 | acceptance time not in the bulk data set |